Keigo Yato
InvestorPrincipal, Investment Group (Ph.D.) at Beyond Next Ventures
About
Keigo Yato holds a Ph.D. and previously conducted research on hepatitis vaccines and viral immune response at the National Institute of Infectious Diseases. He joined Beyond Next Ventures as a student intern during his doctoral studies and became a full-time employee in April 2022, where he focuses on investments in biotechnology and drug discovery.
Invests in
Biotech
Colleagues at Beyond Next Ventures
Akiko Fujii
Investment Group at Beyond Next Ventures
Akira Horiguchi
Former Executive Vice President, Kobayashi Pharmaceutical Co., Ltd. at Beyond Next Ventures
Akito Arima
Executive Officer / Partner at Beyond Next Ventures
Ashish Behera
Investor at Beyond Next Ventures
Devang Thakor
Founder / President, Anioplex, LLC at Beyond Next Ventures
Hiroki Matsumoto
Representative of SubTonic Consulting at Beyond Next Ventures
Hiroki Mikuni
Investor at Beyond Next Ventures
Hiroyuki Kageyama
Principal at Beyond Next Ventures
Frequently asked questions
- Who is Keigo Yato?
- Keigo Yato holds a Ph.D. and previously conducted research on hepatitis vaccines and viral immune response at the National Institute of Infectious Diseases. He joined Beyond Next Ventures as a student intern during his doctoral studies and became a full-time employee in April 2022, where he focuses on investments in biotechnology and drug discovery.
- Where does Keigo Yato work?
- Keigo Yato is Principal, Investment Group (Ph.D.) at Beyond Next Ventures.
- What does Keigo Yato invest in?
- Keigo Yato invests in Biotech.